← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2007Last known activity
Dec 20, 2021
Timeline
1990s
- Jan 1, 1998
Integrium— Founded
Drugs by trial phase (20 distinct, 28 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Diarrhea
- Fatty Liver
- Foot Ulcer
- Heart Failure
- HIV Infections
- Hyperlipidemia, Familial Combined
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypersensitivity
- Hypersensitivity, Immediate
- Hypertension
- Immunologic Deficiency Syndromes
- Neuralgia
- Non-alcoholic Fatty Liver Disease
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Ulcer
Recent trials (29)
- NCT05247528CollaboratorPhase 1Dec 20, 2021
- NCT04754334CollaboratorPhase 3Mar 16, 2021
- NCT04606576CollaboratorPhase 3Nov 30, 2020
- NCT04618744CollaboratorPhase 2Nov 30, 2020
- NCT04618744Overall official - principal investigatorPhase 2Nov 30, 2020
- NCT04192487Overall official - principal investigatorPhase 4Oct 22, 2019
- NCT04150107CollaboratorPhase 2Oct 17, 2019
- NCT04375436CollaboratorPhase 1Oct 10, 2019
- NCT03819881CollaboratorPhase 1Oct 10, 2018
- NCT03467932CollaboratorPhase 2May 29, 2018
- NCT03290248CollaboratorPhase 1/Phase 2Sep 19, 2017
- NCT03156361CollaboratorPhase 2May 18, 2017
- NCT03096392CollaboratorPhase 2Apr 18, 2017
- NCT02954601CollaboratorPhase 2Oct 1, 2016
- NCT02794155CollaboratorPhase 2Jun 1, 2016
Details
- Founded
- Tustin, CA, US Jan 1, 1998
- Last known activity
- Dec 20, 2021